[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359443-105":59,"doc-detail-359443-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","molecular-and-phenotypic-characterization-of-fluid-derived-patient-derived-cell-and-organoid-models-in-advanced-gastric-cancer","Molecular and Phenotypic Characterization of Fluid-Derived Patient-Derived Cell and Organoid Models in Advanced Gastric Cancer","","Patient-derived cells (PDCs) and patient-derived organoids (PDOs) provide complementary preclinical systems, yet their molecular and functional differences remain incompletely defined. This study generated paired PDC and PDO models from malignant ascites or pleural fluid from six patients with advanced gastric cancer and performed integrated multi-omics profiling. Phenotypic assessments included morphology, histology, proliferation, and cell-cycle analyses, with drug-sensitivity testing using four standard chemotherapeutic agents. Results showed platform-dependent molecular signatures, patient-specific chemosensitivity, and biomarker concordance with primary tumors.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/molecular-and-phenotypic-characterization-of-fluid-derived-patient-derived-cell-and-organoid-models-in-advanced-gastric-cancer/359443/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/molecular-and-phenotypic-characterization-of-fluid-derived-patient-derived-cell-and-organoid-models-in-advanced-gastric-cancer/359443.png","ImageObject",300,407,{"name":92,"@type":93},"Connor ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How were PDC and PDO models established in this study?","Question",{"text":112,"@type":113},"Paired patient-derived cell (PDC) and patient-derived organoid (PDO) models were derived from malignant ascites or pleural fluid collected from six patients with advanced gastric cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What types of analyses were used to characterize the models?",{"text":117,"@type":113},"The study combined comprehensive multi-omics profiling (genomic, transcriptomic, and proteomic) with phenotypic characterization including morphological, histological, proliferative, and cell-cycle analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"Did drug responses match between platforms and patients?",{"text":121,"@type":113},"Drug responses differed by platform and by patient, indicating both platform-dependent and patient-specific chemosensitivity across the paired models.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359443,1790937337,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},687207022233,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","J Gastric Cancer. 2026 Apr;26(2):260-278 [https://doi.org/10.5230/jgc.2026.26.e19](https://doi.org/10.5230/jgc.2026.26.e19)[ ](https://doi.org/10.5230/jgc.2026.26.e19)pISSN 2093-582X·eISSN 2093-5641  \nOriginal Article  \nReceived: Nov 10, 2025  \nRevised: Jan 5, 2026  \nAccepted: Jan 15, 2026  \nPublished online: Mar 16, 2026  \nCorrespondence to  \nSun Young Rha  \nSong-Dang Institute for Cancer Research, Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea. Email: [rha7655@yuhs.ac](rha7655@yuhs.ac)  \nCopyright © 2026. Korean Gastric Cancer Association  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ([https://](https://)[ ](https://)[creativecommons.org/licenses/by-nc/4.0](creativecommons.org/licenses/by-nc/4.0)) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nORCID iDs  \nYe Jin Moon  [https://orcid.org/0009-0003-4293-3722](https://orcid.org/0009-0003-4293-3722)[ ](https://orcid.org/0009-0003-4293-3722)Woo Sun Kwon  [https://orcid.org/0000-0003-0268-5624](https://orcid.org/0000-0003-0268-5624)[ ](https://orcid.org/0000-0003-0268-5624)Chan Hee Park  [https://orcid.org/0000-0002-3820-686X](https://orcid.org/0000-0002-3820-686X)Jinsoo Jang  [https://orcid.org/0009-0004-2573-1253](https://orcid.org/0009-0004-2573-1253)[ ](https://orcid.org/0009-0004-2573-1253)Juin Park  [https://orcid.org/0000-0002-5006-1464](https://orcid.org/0000-0002-5006-1464)[ ](https://orcid.org/0000-0002-5006-1464)Byeong Gyu Yoon  [https://orcid.org/0009-0007-0443-135X](https://orcid.org/0009-0007-0443-135X)[ ](https://orcid.org/0009-0007-0443-135X)Han Byeol Mun  [https://orcid.org/0009-0000-2667-4562](https://orcid.org/0009-0000-2667-4562)  \nMolecular and Phenotypic Characterization of Fluid-Derived Patient-Derived Cell and Organoid Models in Advanced Gastric Cancer  \nYe Jin Moon  1,2, Woo Sun Kwon  1, Chan Hee Park  1, Jinsoo Jang  1, Juin Park  1,3, Byeong Gyu Yoon  1,3, Han Byeol Mun  1,2, Namju Kim  1, Choong-kun Lee  1,4, Hei Cheul Jeung  1,5, Su-Jin Shin  6, Tae Soo Kim  1, Sun Young Rha  1,2,3,4  \n1Song-Dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea  \n2Brain Korea 21 Project, Graduate School of Medical Science, Yonsei University College of Medicine, Seoul, Korea 3Department of Medicine, Yonsei University College of Medicine, Seoul, Korea  \n4Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea  \n5Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea  \n6Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea  \nABSTRACT  \nPurpose: Patient-derived cells (PDCs) and patient-derived organoids (PDOs) are complementary preclinical models widely used in translational cancer research. However, their molecular and functional differences have not been systematically characterized. This study established and analyzed paired PDC and PDO models derived from the same gastric cancer ascites to delineate platform-dependent molecular and functional profiles. Materials and Methods: Malignant ascites or pleural fluid obtained from 6 patients with advanced gastric cancer were used to establish paired PDC and PDO models. All pairs underwent comprehensive multi-omics profiling, integrating genomic, transcriptomic, and proteomic data. Phenotypic characterization included morphological, histological, proliferative, and cell cycle analyses. Drug sensitivity assays were performed using 4 chemotherapeutic agents commonly used to treat gastric cancer.  \nResults: The 6 paired PDC and PDO models exhibited distinct morphological characteristics. Whole-genome analyses demonstrated h","cbCaikGHJa7G50u1","https://ap.wps.com/l/cbCaikGHJa7G50u1","pdf",10616955,"English","# Abstract\n## Purpose\n## Materials and Methods\n## Results\n## Conclusions","[{\"question\":\"How were PDC and PDO models established in this study?\",\"answer\":\"Paired patient-derived cell (PDC) and patient-derived organoid (PDO) models were derived from malignant ascites or pleural fluid collected from six patients with advanced gastric cancer.\"},{\"question\":\"What types of analyses were used to characterize the models?\",\"answer\":\"The study combined comprehensive multi-omics profiling (genomic, transcriptomic, and proteomic) with phenotypic characterization including morphological, histological, proliferative, and cell-cycle analyses.\"},{\"question\":\"Did drug responses match between platforms and patients?\",\"answer\":\"Drug responses differed by platform and by patient, indicating both platform-dependent and patient-specific chemosensitivity across the paired models.\"}]","Molecular and Phenotypic Characterization of Fluid-Derived Patient-Derived Cell and Organoid Models in Advanced Gastric Cancer | PDF",1790136912,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76cd2c34b2fa3da65a8373ff0c84451f.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b08538399f73b584badfdc7c2589d137.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdc0e8a5775a7ad0363b9499744ff342.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eaa1b03a014112216a4c3ee8f8f4599c.webp",980,1306]